Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.
Application of targeted nanopore sequencing for the screening and determination of structural variants in patients with Lynch syndrome.
Directing the Immune System via Polymeric Combinations of Molecular Signals
Lung metastasis of transitional cell cancer of the urothelium, with fungus ball-like shadows closely resembling aspergilloma: A case report and review of the literature.
Cystatin C as a p53-inducible apoptotic mediator that regulates cathepsin L activity.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cystatin C as a p53-inducible apoptotic mediator that regulates cathepsin L activity.
Cystatin C as a p53-inducible apoptotic mediator that regulates cathepsin L activity. Cancer Sci. 2016 Mar; 107(3):298-306.
View in:
PubMed
subject areas
Adenocarcinoma
Apoptosis
Base Sequence
Binding Sites
Breast Neoplasms
Cathepsin L
Colorectal Neoplasms
Consensus Sequence
Cystatin C
DNA Damage
Female
Gene Expression Regulation, Neoplastic
HCT116 Cells
HEK293 Cells
Humans
Male
Middle Aged
Mutation
Proportional Hazards Models
Transcriptional Activation
Tumor Suppressor Protein p53
authors with profiles
Yusuke Nakamura